Europe Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
In this region, The Europe injectable drug delivery market is projected to reach USD 264.52 million by 2024, from USD 107.25 million in 2016 growing at a CAGR of 11.9% in the forecast period 2017 to 2024.
Based on geography, the Europe injectable drug delivery market is segmented into 11 geographical regions, such as,
Some of the major players operating in this market are
The Europe injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices.
The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.
On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.
The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anaemia, osteoporosis and others.
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.
On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.
On the basis of distribution channel, the market is classified into hospital pharmacies, pharmacy store, direct tender, and online pharmacy.
Based on geography, the Europe injectable drug delivery market is segmented into 11 geographical regions, such as,
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Turkey
- Belgium
- Netherlands
- Switzerland and
- Rest of Europe.
Some of the major players operating in this market are
- Baxter International, Inc.
- Becton Dickinson and Company
- Gerresheimer AG, Pfizer, Inc.
- Schott AG, Alkermes Plc.
- Eli Lilly and Company
- Sandoz
- Terumo Corporation
- Teva Pharmaceuticals Industries Ltd.
- Ypsomed
- Bespak.
The Europe injectable drug delivery market is segmented into 2 types, namely injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices.
The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.
On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others.
The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anaemia, osteoporosis and others.
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern.
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system.
On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others.
On the basis of distribution channel, the market is classified into hospital pharmacies, pharmacy store, direct tender, and online pharmacy.
1. INTRODUCTION
1.1. OVERVIEW OF EUROPE INJECTABLEDRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF CHRONIC DISEASES
3.1.2. RISING DEMAND OF SELF-INJECTION DEVICES
3.1.3. GROWTH OF BIOLOGICS MARKET
3.1.4. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN DRUG DELIVERY MARKET
3.2. RESTRAINTS
3.2.1. NEEDLESTICK INJURIES AND INFECTIONS
3.2.2. HIGH COST OF DEVELOPMENT
3.2.3. STRICT REGULATORY FRAMEWORK
3.3. OPPORTUNITY
3.3.1. INCREASING DEMAND FOR GENERIC AND BIOSIMILAR DRUGS
3.3.1.1. GENERICS
3.3.1.2. BIOSIMILARS
3.3.2. INCREASING DEMAND FOR CONTRACEPTIVE INJECTABLES
3.3.3. INCREASING DEMAND FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. ALTERNATIVE ROUTE OF DRUG ADMINISTRATION
3.4.2. PRODUCT RECALL
3.4.3. STABILITY OF PRODUCTS
3.4.4. STERILITY OF INJECTIONS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. EUROPE INJECTABLE DRUG DELIVERY MARKET, REGULATORY
6.1. OVERVIEW
6.2. U.S. FDA APPROVAL
6.3. CE MARKING (EUROPEAN CONFORMITY)
6.4. EM (EUROPEAN MEDICINE AGENCY)
7. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY TYPE
7.1. OVERVIEW
7.2. INJECTABLE DRUG DELIVERY DEVICES
7.2.1. CONVENTIONAL INJECTION DEVICES
7.2.2. SELF INJECTION DEVICES
7.2.2.1. NEEDLE FREE INJECTORS (NFI)
7.2.2.2. AUTO INJECTORS
7.2.2.3. PEN INJECTORS
7.2.2.4. WEARABLE INJECTORS
7.3. INJECTABLE DRUG DELIVERY FORMULATION
7.3.1. CONVENTIONAL DRUG DELIVERY FORMULATIONS
7.3.1.1. SOLUTIONS
7.3.1.2. RECONSTITUTED/LYOPHILIZED FORMULATIONS
7.3.1.3. SUSPENSIONS
7.3.1.4. EMULSIONS
7.3.2. NOVEL DRUG DELIVERY FORMULATIONS
7.3.2.1. COLLOIDAL DISPERSIONS
7.3.2.2. MICROPARTICLES
7.3.2.3. LONG ACTING INJECTION FORMULATION
8. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
8.3. HORMONAL DISORDERS
8.3.1. INJECTABLE DRUGS FOR DIABETES
8.3.2. INJECTABLE DRUGS FOR ANEMIA
8.3.3. INJECTABLE DRUGS FOR REPRODUCTIVE HEALTH DISEASE
8.3.4. INJECTABLE DRUGS FOR ANTITHROMBOTIC/THROMBOLYTIC THERAPY
8.3.5. INJECTABLE DRUGS FOR OSTEOPOROSIS
8.3.6. INJECTABLE DRUGS FOR GROWTH HORMONE DISORDERS (GHD)
8.4. ONCOLOGY
8.5. AUTOIMMUNE DISEASES
8.5.1. INJECTABLE DRUGS FOR RHEUMATOID ARTHRITIS
8.5.2. INJECTABLE DRUGS FOR MULTIPLE SCLEROSIS
8.5.3. INJECTABLE DRUGS FOR CROHN’S DISEASES
8.5.4. INJECTABLE DRUGS FOR PSORIASIS
8.5.5. INJECTABLE DRUGS FOR OTHER AUTOIMMUNE DISEASES
8.6. ORPHAN DISEASE
8.7. OTHER APPLICATIONS
8.7.1. INJECTABLE DRUGS FOR PAIN MANAGEMENT
8.7.2. INJECTABLE DRUGS FOR ALLERGY TREATMENT
8.7.3. INJECTABLE DRUGS FOR AESTHETIC TREATMENTS
8.7.4. INJECTABLE DRUGS FOR HEPATITIS C
8.7.5. INJECTABLE DRUGS FOR HEMOPHILIA
9. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN
9.1. OVERVIEW
9.2. CURATIVE CARE
9.3. IMMUNIZATIONS
9.4. OTHER USAGE PATTERN
10. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION
10.1. OVERVIEW
10.2. SKIN
10.3. CIRCULATORY/ MUSKOSKELETAL
10.4. ORGANS
10.5. CENTRAL NERVOUS SYSTEM
11. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY END USER
11.1. OVERVIEW
11.2. HOSPITALS AND CLINICS
11.3. HOME HEALTHCARE SETTINGS
11.4. RESEARCH LABORATORIES
11.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
11.6. OTHER END USERS
12. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
12.1. OVERVIEW
12.1.1. HOSPITAL PHARMACY
12.1.2. PHARMACY STORES
12.1.3. DIRECT TENDER
12.1.4. ONLINE PHARMACY
13. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY GEOGRAPHY
13.1. OVERVIEW
12.2. EUROPE INJECTABLE DRUG DELIVERY MARKET
12.2.1. GERMANY INJECTABLE DRUG DELIVERY MARKET
12.2.2. FRANCE INJECTABLE DRUG DELIVERY MARKET
12.2.3. UK INJECTABLE DRUG DELIVERY MARKET
12.2.4. ITALY INJECTABLE DRUG DELIVERY MARKET
12.2.5. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET
12.2.6. SPAIN INJECTABLE DRUG DELIVERY MARKET
12.2.7. NETHERLAND INJECTABLE DRUG DELIVERY MARKET
12.2.8. RUSSIA INJECTABLE DRUG DELIVERY MARKET
12.2.9. TURKEY INJECTABLE DRUG DELIVERY MARKET
12.2.10. BELGIUM INJECTABLE DRUG DELIVERY MARKET
12.2.11. REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET
14. EUROPE INJECTABLE DRUG DELIVERY MARKET, COMPANY SHARE
14.1. COMPANY SHARE ANALYSIS: EUROPE
15. COMPANY PROFILES
15.1. BECTON, DICKINSON AND COMPANY
15.1.1. COMPANY OVERVIEW
15.1.1.1. DRIVERS EXPLAINED
15.1.1.2. WEAKNESSES EXPLAINED
15.1.1.3. OPPURTUNITIES EXPLAINED
15.1.1.4. THREATS EXPLAINED
15.1.2. PRODUCT PORTFOLIO
15.1.3. RECENT DEVELOPMENTS
15.2. PFIZER
15.2.1. COMPANY OVERVIEW
15.2.1.1. DRIVERS EXPLAINED
15.2.1.2. WEAKNESSES EXPLAINED
15.2.1.3. OPPURTUNITIES EXPLAINED
15.2.1.4. THREATS EXPLAINED
15.2.2. PRODUCT PORTFOLIO
15.2.3. RECENT DEVELOPMENTS
15.3. BAXTER INTERNATIONAL
15.3.1. COMPANY OVERVIEW
15.3.1.1. DRIVERS EXPLAINED
15.3.1.2. WEAKNESSES EXPLAINED
15.3.1.3. OPPURTUNITIES EXPLAINED
15.3.1.4. THREATS EXPLAINED
15.3.2. PRODUCT PORTFOLIO
15.3.3. RECENT DEVELOPMENTS
15.4. GERRESHEIMER AG
15.4.1. COMPANY OVERVIEW
15.4.2. PRODUCT PORTFOLIO
15.4.3. RECENT DEVELOPMENTS
15.5. SCHOTT AG INC.
15.5.1. COMPANY OVERVIEW
15.5.2. PRODUCT PORTFOLIO
15.5.3. RECENT DEVELOPMENTS
15.6. ALKERMES INC.
15.6.1. COMPANY OVERVIEW
15.6.2. PRODUCT PORTFOLIO
15.6.3. RECENT DEVELOPMENTS
15.7. ANTARES PHARMA
15.7.1. COMPANY OVERVIEW
15.7.2. PRODUCT PORTFOLIO
15.7.3. RECENT DEVELOPMENTS
15.8. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)
15.8.1. COMPANY OVERVIEW
15.8.2. PRODUCT PORTFOLIO
15.8.3. RECENT DEVELOPMENTS
15.9. ELCAM MEDICAL
15.9.1. COMPANY OVERVIEW
15.9.2. PRODUCT PORTFOLIO
15.9.3. RECENT DEVELOPMENTS
15.10. ELI LILLY AND COMPANY
15.10.1. COMPANY OVERVIEW
15.10.1.1. DRIVERS EXPLAINED
15.10.1.2. WEAKNESSES EXPLAINED
15.10.1.3. OPPURTUNITIES EXPLAINED
15.10.1.4. THREATS EXPLAINED
15.10.2. PRODUCT PORTFOLIO
15.10.3. RECENT DEVELOPMENTS
15.11. HASELMEIER
15.11.1. COMPANY OVERVIEW
15.11.2. PRODUCT PORTFOLIO
15.11.3. RECENT DEVELOPMENTS
15.12. MYLAN N.V.
15.12.1. COMPANY OVERVIEW
15.12.2. PRODUCT PORTFOLIO
15.12.3. RECENT DEVELOPMENTS
15.13. NOVO NORDISK
15.13.1. COMPANY OVERVIEW
15.13.2. PRODUCT PORTFOLIO
15.13.3. RECENT DEVELOPMENTS
15.14. OWEN MUMFORD LTD
15.14.1. COMPANY OVERVIEW
15.14.2. PRODUCT PORTFOLIO
15.14.3. RECENT DEVELOPMENTS
15.15. SANDOZ INTERNATIONAL GMBH
15.15.1. COMPANY OVERVIEW
15.15.2. PRODUCT PORTFOLIO
15.15.3. RECENT DEVELOPMENTS
15.16. SANOFI
15.16.1. COMPANY OVERVIEW
15.16.2. PRODUCT PORTFOLIO
15.16.3. RECENT DEVELOPMENTS
15.17. TERUMO CORPORATION
15.17.1. COMPANY OVERVIEW
15.17.2. PRODUCT PORTFOLIO
15.17.3. RECENT DEVELOPMENTS
15.18. TEVA PHARMACEUTICAL
15.18.1. COMPANY OVERVIEW
15.18.1.1. DRIVERS EXPLAINED
15.18.1.2. WEAKNESSES EXPLAINED
15.18.1.3. OPPURTUNITIES EXPLAINED
15.18.1.4. THREATS EXPLAINED
15.18.2. PRODUCT PORTFOLIO
15.18.3. RECENT DEVELOPMENTS
15.19. WEST PHARMACEUTICAL SERVICES, INC
15.19.1. COMPANY OVERVIEW
15.19.2. PRODUCT PORTFOLIO
15.19.3. RECENT DEVELOPMENTS
15.20. YPSOMED HOLDING AG
15.20.1. COMPANY OVERVIEW
15.20.2. PRODUCT PORTFOLIO
15.20.3. RECENT DEVELOPMENTS
16. RELATED REPORTS
1.1. OVERVIEW OF EUROPE INJECTABLEDRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF CHRONIC DISEASES
3.1.2. RISING DEMAND OF SELF-INJECTION DEVICES
3.1.3. GROWTH OF BIOLOGICS MARKET
3.1.4. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN DRUG DELIVERY MARKET
3.2. RESTRAINTS
3.2.1. NEEDLESTICK INJURIES AND INFECTIONS
3.2.2. HIGH COST OF DEVELOPMENT
3.2.3. STRICT REGULATORY FRAMEWORK
3.3. OPPORTUNITY
3.3.1. INCREASING DEMAND FOR GENERIC AND BIOSIMILAR DRUGS
3.3.1.1. GENERICS
3.3.1.2. BIOSIMILARS
3.3.2. INCREASING DEMAND FOR CONTRACEPTIVE INJECTABLES
3.3.3. INCREASING DEMAND FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. ALTERNATIVE ROUTE OF DRUG ADMINISTRATION
3.4.2. PRODUCT RECALL
3.4.3. STABILITY OF PRODUCTS
3.4.4. STERILITY OF INJECTIONS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. EUROPE INJECTABLE DRUG DELIVERY MARKET, REGULATORY
6.1. OVERVIEW
6.2. U.S. FDA APPROVAL
6.3. CE MARKING (EUROPEAN CONFORMITY)
6.4. EM (EUROPEAN MEDICINE AGENCY)
7. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY TYPE
7.1. OVERVIEW
7.2. INJECTABLE DRUG DELIVERY DEVICES
7.2.1. CONVENTIONAL INJECTION DEVICES
7.2.2. SELF INJECTION DEVICES
7.2.2.1. NEEDLE FREE INJECTORS (NFI)
7.2.2.2. AUTO INJECTORS
7.2.2.3. PEN INJECTORS
7.2.2.4. WEARABLE INJECTORS
7.3. INJECTABLE DRUG DELIVERY FORMULATION
7.3.1. CONVENTIONAL DRUG DELIVERY FORMULATIONS
7.3.1.1. SOLUTIONS
7.3.1.2. RECONSTITUTED/LYOPHILIZED FORMULATIONS
7.3.1.3. SUSPENSIONS
7.3.1.4. EMULSIONS
7.3.2. NOVEL DRUG DELIVERY FORMULATIONS
7.3.2.1. COLLOIDAL DISPERSIONS
7.3.2.2. MICROPARTICLES
7.3.2.3. LONG ACTING INJECTION FORMULATION
8. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
8.3. HORMONAL DISORDERS
8.3.1. INJECTABLE DRUGS FOR DIABETES
8.3.2. INJECTABLE DRUGS FOR ANEMIA
8.3.3. INJECTABLE DRUGS FOR REPRODUCTIVE HEALTH DISEASE
8.3.4. INJECTABLE DRUGS FOR ANTITHROMBOTIC/THROMBOLYTIC THERAPY
8.3.5. INJECTABLE DRUGS FOR OSTEOPOROSIS
8.3.6. INJECTABLE DRUGS FOR GROWTH HORMONE DISORDERS (GHD)
8.4. ONCOLOGY
8.5. AUTOIMMUNE DISEASES
8.5.1. INJECTABLE DRUGS FOR RHEUMATOID ARTHRITIS
8.5.2. INJECTABLE DRUGS FOR MULTIPLE SCLEROSIS
8.5.3. INJECTABLE DRUGS FOR CROHN’S DISEASES
8.5.4. INJECTABLE DRUGS FOR PSORIASIS
8.5.5. INJECTABLE DRUGS FOR OTHER AUTOIMMUNE DISEASES
8.6. ORPHAN DISEASE
8.7. OTHER APPLICATIONS
8.7.1. INJECTABLE DRUGS FOR PAIN MANAGEMENT
8.7.2. INJECTABLE DRUGS FOR ALLERGY TREATMENT
8.7.3. INJECTABLE DRUGS FOR AESTHETIC TREATMENTS
8.7.4. INJECTABLE DRUGS FOR HEPATITIS C
8.7.5. INJECTABLE DRUGS FOR HEMOPHILIA
9. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN
9.1. OVERVIEW
9.2. CURATIVE CARE
9.3. IMMUNIZATIONS
9.4. OTHER USAGE PATTERN
10. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION
10.1. OVERVIEW
10.2. SKIN
10.3. CIRCULATORY/ MUSKOSKELETAL
10.4. ORGANS
10.5. CENTRAL NERVOUS SYSTEM
11. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY END USER
11.1. OVERVIEW
11.2. HOSPITALS AND CLINICS
11.3. HOME HEALTHCARE SETTINGS
11.4. RESEARCH LABORATORIES
11.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
11.6. OTHER END USERS
12. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
12.1. OVERVIEW
12.1.1. HOSPITAL PHARMACY
12.1.2. PHARMACY STORES
12.1.3. DIRECT TENDER
12.1.4. ONLINE PHARMACY
13. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY GEOGRAPHY
13.1. OVERVIEW
12.2. EUROPE INJECTABLE DRUG DELIVERY MARKET
12.2.1. GERMANY INJECTABLE DRUG DELIVERY MARKET
12.2.2. FRANCE INJECTABLE DRUG DELIVERY MARKET
12.2.3. UK INJECTABLE DRUG DELIVERY MARKET
12.2.4. ITALY INJECTABLE DRUG DELIVERY MARKET
12.2.5. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET
12.2.6. SPAIN INJECTABLE DRUG DELIVERY MARKET
12.2.7. NETHERLAND INJECTABLE DRUG DELIVERY MARKET
12.2.8. RUSSIA INJECTABLE DRUG DELIVERY MARKET
12.2.9. TURKEY INJECTABLE DRUG DELIVERY MARKET
12.2.10. BELGIUM INJECTABLE DRUG DELIVERY MARKET
12.2.11. REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET
14. EUROPE INJECTABLE DRUG DELIVERY MARKET, COMPANY SHARE
14.1. COMPANY SHARE ANALYSIS: EUROPE
15. COMPANY PROFILES
15.1. BECTON, DICKINSON AND COMPANY
15.1.1. COMPANY OVERVIEW
15.1.1.1. DRIVERS EXPLAINED
15.1.1.2. WEAKNESSES EXPLAINED
15.1.1.3. OPPURTUNITIES EXPLAINED
15.1.1.4. THREATS EXPLAINED
15.1.2. PRODUCT PORTFOLIO
15.1.3. RECENT DEVELOPMENTS
15.2. PFIZER
15.2.1. COMPANY OVERVIEW
15.2.1.1. DRIVERS EXPLAINED
15.2.1.2. WEAKNESSES EXPLAINED
15.2.1.3. OPPURTUNITIES EXPLAINED
15.2.1.4. THREATS EXPLAINED
15.2.2. PRODUCT PORTFOLIO
15.2.3. RECENT DEVELOPMENTS
15.3. BAXTER INTERNATIONAL
15.3.1. COMPANY OVERVIEW
15.3.1.1. DRIVERS EXPLAINED
15.3.1.2. WEAKNESSES EXPLAINED
15.3.1.3. OPPURTUNITIES EXPLAINED
15.3.1.4. THREATS EXPLAINED
15.3.2. PRODUCT PORTFOLIO
15.3.3. RECENT DEVELOPMENTS
15.4. GERRESHEIMER AG
15.4.1. COMPANY OVERVIEW
15.4.2. PRODUCT PORTFOLIO
15.4.3. RECENT DEVELOPMENTS
15.5. SCHOTT AG INC.
15.5.1. COMPANY OVERVIEW
15.5.2. PRODUCT PORTFOLIO
15.5.3. RECENT DEVELOPMENTS
15.6. ALKERMES INC.
15.6.1. COMPANY OVERVIEW
15.6.2. PRODUCT PORTFOLIO
15.6.3. RECENT DEVELOPMENTS
15.7. ANTARES PHARMA
15.7.1. COMPANY OVERVIEW
15.7.2. PRODUCT PORTFOLIO
15.7.3. RECENT DEVELOPMENTS
15.8. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)
15.8.1. COMPANY OVERVIEW
15.8.2. PRODUCT PORTFOLIO
15.8.3. RECENT DEVELOPMENTS
15.9. ELCAM MEDICAL
15.9.1. COMPANY OVERVIEW
15.9.2. PRODUCT PORTFOLIO
15.9.3. RECENT DEVELOPMENTS
15.10. ELI LILLY AND COMPANY
15.10.1. COMPANY OVERVIEW
15.10.1.1. DRIVERS EXPLAINED
15.10.1.2. WEAKNESSES EXPLAINED
15.10.1.3. OPPURTUNITIES EXPLAINED
15.10.1.4. THREATS EXPLAINED
15.10.2. PRODUCT PORTFOLIO
15.10.3. RECENT DEVELOPMENTS
15.11. HASELMEIER
15.11.1. COMPANY OVERVIEW
15.11.2. PRODUCT PORTFOLIO
15.11.3. RECENT DEVELOPMENTS
15.12. MYLAN N.V.
15.12.1. COMPANY OVERVIEW
15.12.2. PRODUCT PORTFOLIO
15.12.3. RECENT DEVELOPMENTS
15.13. NOVO NORDISK
15.13.1. COMPANY OVERVIEW
15.13.2. PRODUCT PORTFOLIO
15.13.3. RECENT DEVELOPMENTS
15.14. OWEN MUMFORD LTD
15.14.1. COMPANY OVERVIEW
15.14.2. PRODUCT PORTFOLIO
15.14.3. RECENT DEVELOPMENTS
15.15. SANDOZ INTERNATIONAL GMBH
15.15.1. COMPANY OVERVIEW
15.15.2. PRODUCT PORTFOLIO
15.15.3. RECENT DEVELOPMENTS
15.16. SANOFI
15.16.1. COMPANY OVERVIEW
15.16.2. PRODUCT PORTFOLIO
15.16.3. RECENT DEVELOPMENTS
15.17. TERUMO CORPORATION
15.17.1. COMPANY OVERVIEW
15.17.2. PRODUCT PORTFOLIO
15.17.3. RECENT DEVELOPMENTS
15.18. TEVA PHARMACEUTICAL
15.18.1. COMPANY OVERVIEW
15.18.1.1. DRIVERS EXPLAINED
15.18.1.2. WEAKNESSES EXPLAINED
15.18.1.3. OPPURTUNITIES EXPLAINED
15.18.1.4. THREATS EXPLAINED
15.18.2. PRODUCT PORTFOLIO
15.18.3. RECENT DEVELOPMENTS
15.19. WEST PHARMACEUTICAL SERVICES, INC
15.19.1. COMPANY OVERVIEW
15.19.2. PRODUCT PORTFOLIO
15.19.3. RECENT DEVELOPMENTS
15.20. YPSOMED HOLDING AG
15.20.1. COMPANY OVERVIEW
15.20.2. PRODUCT PORTFOLIO
15.20.3. RECENT DEVELOPMENTS
16. RELATED REPORTS
LIST OF TABLES
TABLE 1 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 2 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 3 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 4 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 5 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 6 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 7 EUROPE SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 8 EUROPE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 9 EUROPE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 10 EUROPE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 11 EUROPE AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 12 EUROPE AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 13 EUROPE AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 14 EUROPE AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 15 EUROPE PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 16 EUROPE PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 17 EUROPE PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 18 EUROPE INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 19 EUROPE CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 20 EUROPE NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 21 EUROPE COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 22 EUROPE NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 23 EUROPE MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 24 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 25 EUROPE AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 26 EUROPE HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 27 EUROPE OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 28 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 29 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 30 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 31 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 32 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 33 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 34 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 35 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 36 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 37 GERMANY SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 38 GERMANY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 39 GERMANY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 40 GERMANY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 41 GERMANY AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 42 GERMANY AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 43 GERMANY AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 44 GERMANY AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 45 GERMANY PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 46 GERMANY PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 47 GERMANY PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 48 GERMANY INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 49 GERMANY CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 50 GERMANY NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 51 GERMANY COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 52 GERMANY NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 53 GERMANY MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 54 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 55 GERMANY AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 56 GERMANY HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 57 GERMANY OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 58 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 59 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 60 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015–2024 (USD MILLION)
TABLE 61 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 62 FRANCE INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 63 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 64 FRANCE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 65 FRANCE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 66 FRANCE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 67 FRANCE SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 68 FRANCE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 69 FRANCE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 70 FRANCE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 71 FRANCE AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 72 FRANCE AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 73 FRANCE AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 74 FRANCE AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 75 FRANCE PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 76 FRANCE PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 77 FRANCE PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 78 FRANCE INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 79 FRANCE CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 80 FRANCE NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 81 FRANCE COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 82 FRANCE NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 83 FRANCE MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 84 FRANCE INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 85 FRANCE AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 86 FRANCE HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 87 FRANCE OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 88 FRANCE INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 89 FRANCE INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 90 FRANCE INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 91 FRANCE INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 92 UK INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 93 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 94 UK CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 95 UK CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 96 UK CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 97 UK SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 98 UK NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 99 UK NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 100 UK NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 101 UK AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 102 UK AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 103 UK AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 104 UK AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 105 UK PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 106 UK PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 107 UK PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 108 UK INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 109 UK CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 110 UK NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 111 UK COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 112 UK NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 113 UK MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 114 UK INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 115 UK AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 116 UK HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 117 UK OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 118 UK INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 119 UK INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 120 UK INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 121 UK INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 122 ITALY INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 123 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 124 ITALY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 125 ITALY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 126 ITALY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 127 ITALY SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 128 ITALY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 129 ITALY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 130 ITALY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 131 ITALY AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 132 ITALY AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 133 ITALY AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 134 ITALY AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 135 ITALY PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 136 ITALY PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 137 ITALY PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 138 ITALY INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 139 ITALY CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 140 ITALY NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 141 ITALY COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 142 ITALY NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 143 ITALY MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 144 ITALY INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 145 ITALY AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 146 ITALY HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 147 ITALY OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 148 ITALY INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 149 ITALY INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 150 ITALY INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 151 ITALY INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 152 SWITZERLAND INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 153 SWITZERLAND INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 154 SWITZERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 155 SWITZERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 156 SWITZERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 157 SWITZERLAND SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 158 SWITZERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 159 SWITZERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 160 SWITZERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 161 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 162 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 163 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 164 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 165 SWITZERLAND PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 166 SWITZERLAND PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 167 SWITZERLAND PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 168 SWITZERLAND INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 169 SWITZERLAND CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 170 SWITZERLAND NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 171 SWITZERLAND COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 172 SWITZERLAND NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 173 SWITZERLAND MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 174 SWITZERLAND INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 175 SWITZERLAND AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 176 SWITZERLAND HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 177 SWITZERLAND OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 178 SWITZERLAND INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 179 SWITZERLAND INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 180 SWITZERLAND INJECTABLE DRUG DELIVERY MARKET, BY END USER,2015– 2024 (USD MILLION)
TABLE 181 SWITZERLAND INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 182 SPAIN INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 183 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 184 SPAIN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 185 SPAIN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 186 SPAIN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 187 SPAIN SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 188 SPAIN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 189 SPAIN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 190 SPAIN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 191 SPAIN AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 192 SPAIN AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 193 SPAIN AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 194 SPAIN AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 195 SPAIN PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 196 SPAIN PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 197 SPAIN PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 198 SPAIN INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 199 SPAIN CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 200 SPAIN NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 201 SPAIN COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 202 SPAIN NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 203 SPAIN MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 204 SPAIN INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 205 SPAIN AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 206 SPAIN HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 207 SPAIN OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 208 SPAIN INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 209 SPAIN INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 210 SPAIN INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 211 SPAIN INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL,2015– 2024 (USD MILLION)
TABLE 212 NETHERLAND INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 213 NETHERLAND INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 214 NETHERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 215 NETHERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 216 NETHERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 217 NETHERLAND SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 218 NETHERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 219 NETHERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 220 NETHERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 221 NETHERLAND AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 222 NETHERLAND AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 223 NETHERLAND AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 224 NETHERLAND AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 225 NETHERLAND PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 226 NETHERLAND PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 227 NETHERLAND PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 228 NETHERLAND INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 229 NETHERLAND CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 230 NETHERLAND NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 231 NETHERLAND COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 232 NETHERLAND NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 233 NETHERLAND MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 234 NETHERLAND INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 235 NETHERLAND AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 236 NETHERLAND HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 237 NETHERLAND OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 238 NETHERLAND INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 239 NETHERLAND INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 240 NETHERLAND INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 241 NETHERLAND INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 242 RUSSIA INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 243 RUSSIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 244 RUSSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 245 RUSSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 246 RUSSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 247 RUSSIA SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 248 RUSSIA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 249 RUSSIA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 250 RUSSIA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 251 RUSSIA AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 252 RUSSIA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 253 RUSSIA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 254 RUSSIA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 255 RUSSIA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 256 RUSSIA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 257 RUSSIA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 258 RUSSIA INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 259 RUSSIA CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 260 RUSSIA NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 261 RUSSIA COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 262 RUSSIA NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 263 RUSSIA MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 264 RUSSIA INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 265 RUSSIA AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 266 RUSSIA HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 267 RUSSIA OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 268 RUSSIA INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 269 RUSSIA INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 270 RUSSIA INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 271 RUSSIA INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 272 TURKEY INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 273 TURKEY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 274 TURKEY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 275 TURKEY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 276 TURKEY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 277 TURKEY SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 278 TURKEY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 279 TURKEY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 280 TURKEY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 281 TURKEY AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 282 TURKEY AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 283 TURKEY AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 284 TURKEY AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 285 TURKEY PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 286 TURKEY PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 287 TURKEY PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 288 TURKEY INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 289 TURKEY CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 290 TURKEY NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 291 TURKEY COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 292 TURKEY NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 293 TURKEY MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 294 TURKEY INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 295 TURKEY AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 296 TURKEY HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 297 TURKEY OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 298 TURKEY INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 299 TURKEY INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 300 TURKEY INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 301 TURKEY INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 302 BELGIUM INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 303 BELGIUM INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 304 BELGIUM CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 305 BELGIUM CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 306 BELGIUM CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 307 BELGIUM SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 308 BELGIUM NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 309 BELGIUM NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 310 BELGIUM NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 311 BELGIUM AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 312 BELGIUM AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 313 BELGIUM AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 314 BELGIUM AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 315 BELGIUM PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 316 BELGIUM PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 317 BELGIUM PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 318 BELGIUM INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 319 BELGIUM CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 320 BELGIUM NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 321 BELGIUM COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 322 BELGIUM NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 323 BELGIUM MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
...
TABLE 332 REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 –2024(USD MILLION)
TABLE 1 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD MILLION)
TABLE 2 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 3 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 4 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 5 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 6 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 7 EUROPE SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 8 EUROPE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 9 EUROPE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 10 EUROPE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 11 EUROPE AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 12 EUROPE AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 13 EUROPE AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 14 EUROPE AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 15 EUROPE PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 16 EUROPE PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 17 EUROPE PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 18 EUROPE INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 19 EUROPE CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 20 EUROPE NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 21 EUROPE COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 22 EUROPE NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 23 EUROPE MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 24 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 25 EUROPE AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 26 EUROPE HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 27 EUROPE OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 28 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 29 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 30 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 31 EUROPE INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 32 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 33 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 34 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 35 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 36 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 37 GERMANY SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 38 GERMANY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 39 GERMANY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 40 GERMANY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 41 GERMANY AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 42 GERMANY AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 43 GERMANY AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 44 GERMANY AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 45 GERMANY PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 46 GERMANY PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 47 GERMANY PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 48 GERMANY INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 49 GERMANY CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 50 GERMANY NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 51 GERMANY COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 52 GERMANY NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 53 GERMANY MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 54 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 55 GERMANY AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 56 GERMANY HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 57 GERMANY OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 58 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 59 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 60 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015–2024 (USD MILLION)
TABLE 61 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 62 FRANCE INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 63 FRANCE INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 64 FRANCE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 65 FRANCE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 66 FRANCE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 67 FRANCE SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 68 FRANCE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 69 FRANCE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 70 FRANCE NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 71 FRANCE AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 72 FRANCE AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 73 FRANCE AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 74 FRANCE AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 75 FRANCE PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 76 FRANCE PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 77 FRANCE PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 78 FRANCE INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 79 FRANCE CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 80 FRANCE NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 81 FRANCE COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 82 FRANCE NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 83 FRANCE MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 84 FRANCE INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 85 FRANCE AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 86 FRANCE HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 87 FRANCE OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 88 FRANCE INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 89 FRANCE INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 90 FRANCE INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 91 FRANCE INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 92 UK INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 93 UK INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 94 UK CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 95 UK CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 96 UK CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 97 UK SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 98 UK NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 99 UK NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 100 UK NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 101 UK AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 102 UK AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 103 UK AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 104 UK AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 105 UK PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 106 UK PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 107 UK PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 108 UK INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 109 UK CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 110 UK NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 111 UK COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 112 UK NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 113 UK MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 114 UK INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 115 UK AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 116 UK HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 117 UK OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 118 UK INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 119 UK INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 120 UK INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 121 UK INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 122 ITALY INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 123 ITALY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 124 ITALY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 125 ITALY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 126 ITALY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 127 ITALY SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 128 ITALY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 129 ITALY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 130 ITALY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 131 ITALY AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 132 ITALY AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 133 ITALY AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 134 ITALY AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 135 ITALY PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 136 ITALY PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 137 ITALY PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 138 ITALY INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 139 ITALY CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 140 ITALY NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 141 ITALY COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 142 ITALY NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 143 ITALY MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 144 ITALY INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 145 ITALY AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 146 ITALY HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 147 ITALY OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 148 ITALY INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 149 ITALY INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 150 ITALY INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 151 ITALY INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 152 SWITZERLAND INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 153 SWITZERLAND INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 154 SWITZERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 155 SWITZERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 156 SWITZERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 157 SWITZERLAND SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 158 SWITZERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 159 SWITZERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 160 SWITZERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 161 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 162 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 163 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 164 SWITZERLAND AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 165 SWITZERLAND PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 166 SWITZERLAND PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 167 SWITZERLAND PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 168 SWITZERLAND INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 169 SWITZERLAND CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 170 SWITZERLAND NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 171 SWITZERLAND COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 172 SWITZERLAND NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 173 SWITZERLAND MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 174 SWITZERLAND INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 175 SWITZERLAND AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 176 SWITZERLAND HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 177 SWITZERLAND OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 178 SWITZERLAND INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 179 SWITZERLAND INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 180 SWITZERLAND INJECTABLE DRUG DELIVERY MARKET, BY END USER,2015– 2024 (USD MILLION)
TABLE 181 SWITZERLAND INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 182 SPAIN INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 183 SPAIN INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 184 SPAIN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 185 SPAIN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 186 SPAIN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 187 SPAIN SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 188 SPAIN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 189 SPAIN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 190 SPAIN NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 191 SPAIN AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 192 SPAIN AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 193 SPAIN AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 194 SPAIN AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 195 SPAIN PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 196 SPAIN PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 197 SPAIN PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 198 SPAIN INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 199 SPAIN CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 200 SPAIN NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 201 SPAIN COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 202 SPAIN NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 203 SPAIN MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 204 SPAIN INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 205 SPAIN AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 206 SPAIN HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 207 SPAIN OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 208 SPAIN INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 209 SPAIN INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 210 SPAIN INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 211 SPAIN INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL,2015– 2024 (USD MILLION)
TABLE 212 NETHERLAND INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 213 NETHERLAND INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 214 NETHERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 215 NETHERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 216 NETHERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 217 NETHERLAND SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 218 NETHERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 219 NETHERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 220 NETHERLAND NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 221 NETHERLAND AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 222 NETHERLAND AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 223 NETHERLAND AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 224 NETHERLAND AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 225 NETHERLAND PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 226 NETHERLAND PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 227 NETHERLAND PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 228 NETHERLAND INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 229 NETHERLAND CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 230 NETHERLAND NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 231 NETHERLAND COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 232 NETHERLAND NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 233 NETHERLAND MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 234 NETHERLAND INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 235 NETHERLAND AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 236 NETHERLAND HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 237 NETHERLAND OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 238 NETHERLAND INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 239 NETHERLAND INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 240 NETHERLAND INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 241 NETHERLAND INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 242 RUSSIA INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 243 RUSSIA INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 244 RUSSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 245 RUSSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 246 RUSSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 247 RUSSIA SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 248 RUSSIA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 249 RUSSIA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 250 RUSSIA NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 251 RUSSIA AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 252 RUSSIA AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024 (USD MILLION)
TABLE 253 RUSSIA AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 254 RUSSIA AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 255 RUSSIA PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024 (USD MILLION)
TABLE 256 RUSSIA PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024 (USD MILLION)
TABLE 257 RUSSIA PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024 (USD MILLION)
TABLE 258 RUSSIA INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 259 RUSSIA CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 260 RUSSIA NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 261 RUSSIA COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 262 RUSSIA NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 263 RUSSIA MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 264 RUSSIA INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 265 RUSSIA AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 266 RUSSIA HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 267 RUSSIA OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 268 RUSSIA INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 269 RUSSIA INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 270 RUSSIA INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 271 RUSSIA INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 272 TURKEY INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 273 TURKEY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 274 TURKEY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 275 TURKEY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 276 TURKEY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 277 TURKEY SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024 (USD MILLION)
TABLE 278 TURKEY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 279 TURKEY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 280 TURKEY NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 281 TURKEY AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 282 TURKEY AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 283 TURKEY AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 284 TURKEY AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 285 TURKEY PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 286 TURKEY PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 287 TURKEY PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 288 TURKEY INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 289 TURKEY CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 290 TURKEY NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 291 TURKEY COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 292 TURKEY NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 293 TURKEY MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 294 TURKEY INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 295 TURKEY AUTOIMMUNE DISEASES INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 296 TURKEY HORMONAL DISORDERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 297 TURKEY OTHERS INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION, 2015 – 2024 (USD MILLION)
TABLE 298 TURKEY INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN, 2015– 2024 (USD MILLION)
TABLE 299 TURKEY INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION, 2015– 2024 (USD MILLION)
TABLE 300 TURKEY INJECTABLE DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD MILLION)
TABLE 301 TURKEY INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD MILLION)
TABLE 302 BELGIUM INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 303 BELGIUM INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD MILLION)
TABLE 304 BELGIUM CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY MATERIAL, 2015 – 2024(USD MILLION)
TABLE 305 BELGIUM CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY PRODUCT TYPE, 2015 – 2024(USD MILLION)
TABLE 306 BELGIUM CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 307 BELGIUM SELF INJECTION DEVICE MARKET, BY TYPE, 2015 – 2024(USD MILLION)
TABLE 308 BELGIUM NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 309 BELGIUM NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 310 BELGIUM NEEDLE FREE INJECTORS (NFI) DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 311 BELGIUM AUTO INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 312 BELGIUM AUTO INJECTORS DEVICE MARKET, BY TECHNOLOGY, 2015 – 2024(USD MILLION)
TABLE 313 BELGIUM AUTO INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 314 BELGIUM AUTO INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 315 BELGIUM PEN INJECTORS DEVICE MARKET, BY PRODUCT, 2015 – 2024(USD MILLION)
TABLE 316 BELGIUM PEN INJECTORS DEVICE MARKET, BY DESIGN, 2015 – 2024(USD MILLION)
TABLE 317 BELGIUM PEN INJECTORS DEVICE MARKET, BY USABILITY, 2015 – 2024(USD MILLION)
TABLE 318 BELGIUM INJECTABLE DRUG DELIVERY FORMULATION MARKET, BY PRODUCT TYPE, 2015– 2024 (USD MILLION)
TABLE 319 BELGIUM CONVENTIONAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 320 BELGIUM NOVEL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 321 BELGIUM COLLOIDAL DISPERSION DRUG DELIVERY FORMULATION, BY TYPE 2015 – 2024 (USD MILLION)
TABLE 322 BELGIUM NANOPARTICLES COLLOIDAL DISPERSIONS DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
TABLE 323 BELGIUM MICROPARTICLES DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD MILLION)
...
TABLE 332 REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET, BY TYPE, 2015 –2024(USD MILLION)
LIST OF FIGURES
FIGURE 1 EUROPE INJECTABLE DRUG DELIVERY MARKET: SEGMENTATION
FIGURE 2 EUROPE INJECTABLE DRUG DELIVERY MARKET: GEOGRAPHIC SCOPE
FIGURE 3 EUROPE INJECTABLE DRUG DELIVERY MARKET: DATA TRIANGULATION
FIGURE 4 EUROPE INJECTABLE DRUG DELIVERY MARKET: RESEARCH SNAPSHOT
FIGURE 5 EUROPE INJECTABLE DRUG DELIVERY MARKET: BOTTOM UP APPROACH
FIGURE 6 EUROPE INJECTABLE DRUG DELIVERY MARKET: TOP DOWN APPROACH
FIGURE 7 EUROPE INJECTABLE DRUG DELIVERY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE INJECTABLE DRUG DELIVERY MARKET: BY TYPE, SNAPSHOT 2016
FIGURE 9 EUROPE INJECTABLE DRUG DELIVERY MARKET: BY APPLICATION, SNAPSHOT 2016
FIGURE 10 EUROPE INJECTABLE DRUG DELIVERY MARKET: BY USAGE PATTERN, SNAPSHOT 2016
FIGURE 11 EUROPE INJECTABLE DRUG DELIVERY MARKET: BY MODE OF ADMINISTRATION, SNAPSHOT 2016
FIGURE 12 EUROPE INJECTABLE DRUG DELIVERY MARKET DOMINATED BY HOSPITAL AND CLIINICS SEGMENT
FIGURE 13 EUROPE INJECTABLE DRUG DELIVERYMARKET:BY END-USER, SNAPSHOT 2016
FIGURE 14 EUROPE INJECTABLE DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016
FIGURE 15 EUROPEAN INJECTABLE DRUG DELIVERY MARKET SNAPSHOT (2017)
FIGURE 1 EUROPE INJECTABLE DRUG DELIVERY MARKET: SEGMENTATION
FIGURE 2 EUROPE INJECTABLE DRUG DELIVERY MARKET: GEOGRAPHIC SCOPE
FIGURE 3 EUROPE INJECTABLE DRUG DELIVERY MARKET: DATA TRIANGULATION
FIGURE 4 EUROPE INJECTABLE DRUG DELIVERY MARKET: RESEARCH SNAPSHOT
FIGURE 5 EUROPE INJECTABLE DRUG DELIVERY MARKET: BOTTOM UP APPROACH
FIGURE 6 EUROPE INJECTABLE DRUG DELIVERY MARKET: TOP DOWN APPROACH
FIGURE 7 EUROPE INJECTABLE DRUG DELIVERY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE INJECTABLE DRUG DELIVERY MARKET: BY TYPE, SNAPSHOT 2016
FIGURE 9 EUROPE INJECTABLE DRUG DELIVERY MARKET: BY APPLICATION, SNAPSHOT 2016
FIGURE 10 EUROPE INJECTABLE DRUG DELIVERY MARKET: BY USAGE PATTERN, SNAPSHOT 2016
FIGURE 11 EUROPE INJECTABLE DRUG DELIVERY MARKET: BY MODE OF ADMINISTRATION, SNAPSHOT 2016
FIGURE 12 EUROPE INJECTABLE DRUG DELIVERY MARKET DOMINATED BY HOSPITAL AND CLIINICS SEGMENT
FIGURE 13 EUROPE INJECTABLE DRUG DELIVERYMARKET:BY END-USER, SNAPSHOT 2016
FIGURE 14 EUROPE INJECTABLE DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016
FIGURE 15 EUROPEAN INJECTABLE DRUG DELIVERY MARKET SNAPSHOT (2017)
